MA181720

CD138 Monoclonal Antibody (B-A38), FITC, Invitrogen™

Manufacturer: Thermo Scientific

Select a Size

Pack Size SKU Availability Price
Each of 1 MA181720-Each-of-1 In Stock ₹ 60,075.00

MA181720 - Each of 1

₹ 60,075.00

In Stock

Quantity

1

Base Price: ₹ 60,075.00

GST (18%): ₹ 10,813.50

Total Price: ₹ 70,888.50

Antigen

CD138

Classification

Monoclonal

Concentration

0.1 mg/mL

Formulation

PBS with 1% BSA and 0.09% sodium azide

Gene Accession No.

P18827

Gene Symbols

Sdc1

Immunogen

U266 cell line.

Quantity

100 μg

Primary or Secondary

Primary

Target Species

Human

Product Type

Antibody

Isotype

IgG1

Applications

Flow Cytometry

Clone

B-A38

Conjugate

FITC

Gene

Sdc1

Gene Alias

AA408134; AA409076; CD antigen 138; CD138; CD138 antigen; heparan sulfate proteoglycan fibroblast growth factor receptor; HSPG; sCD138; SDC; Sdc1; soluble CD138; Sstn; syn-1; Synd; SYND1; Synd-1; SYNDECA; syndecan; syndecan 1; syndecan proteoglycan 1; Syndecan1; syndecan-1; synstatin

Host Species

Mouse

Purification Method

Ion-exchange chromatography

Regulatory Status

RUO

Gene ID (Entrez)

6382

Content And Storage

Store at 4°C short term. For long term storage, store at -20°C, avoiding freeze/thaw cycles. Store in the dark.

Form

Liquid

Related Products

Img

Thermo Scientific

MA182739

--

Img

Thermo Scientific

MA180943

--

Img

Thermo Scientific

MA181261

--

Img

Thermo Scientific

MA180578

--

Img

Thermo Scientific

MA180164

--

Img

Thermo Scientific

MA17322

--

Img

Thermo Scientific

MA125948

--

Img

Thermo Scientific

MA170091

--

Description

  • For FACS analysis, use 10 μL of the suggested working dilution to label 1x10^6 cells in 100 μL
  • Mouse anti human CD138 antibody, clone B-A38 recognizes human CD138, also known as Syndecan-1 (SDC-1)
  • CD138 (syndecan 1) is a transmembrane proteoglycan that can bind a variety of cytokines and modulate their activity, as well as the activity of extracellular matrix components and influence many developmental processes
  • CD138 is expressed mainly in differentiating keratinocytes and is transiently upregulated in all layers of the epidermis upon tissue injury
  • It is also highly expressed on plasma cells and can be detected even on fibroblasts, vascular smooth muscle cells and endothelial cells
  • Up-regulation and down-regulation of CD138 on the cell surface often correlates with the gain of cancerous characteristics
  • Serum levels of the shedded soluble sCD138 are used as a prognostic factor of cancerogenesis.